Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $9.45 and last traded at $9.45, with a volume of 536 shares. The stock had previously closed at $9.05.
Aspen Pharmacare Stock Performance
The business has a 50-day moving average price of $8.89 and a two-hundred day moving average price of $8.13. The company has a current ratio of 3.64, a quick ratio of 2.66 and a debt-to-equity ratio of 0.36.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Read More
- Five stocks we like better than Aspen Pharmacare
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
- Boxabl Disrupts Housing With A Tiny Float IPO
- Robotaxi Mode Engaged: Tesla Starts Monetizing Its Florida Fleet
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
